Eastwood Bio-Medical Canada Inc
Research Eastwood Bio-Medical Canada Inc (EBM) on Bullrun: market cap CAD 68.89M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerEBM
- ExchangeV
- CountryCanada
- SectorConsumer Defensive
- IndustryFood Distribution
- CurrencyCAD
- Market capCAD 68.89M
- Financial periodQ1 2026
- RevenueCAD 152.22K
- Net income-CAD 20.73K
- Free cash flow-CAD 900
- Gross margin68.4%
Valuation Snapshot
latest market cap is CAD 68.89M.
About Eastwood Bio-Medical Canada Inc
Eastwood Bio-Medical Canada Inc. markets, develops research, and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin, which provides natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. It also offers Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance;
Frequently asked questions
What is Eastwood Bio-Medical Canada Inc's market cap?
Eastwood Bio-Medical Canada Inc's market capitalization is CAD 68.89M.
What does Eastwood Bio-Medical Canada Inc do?
Eastwood Bio-Medical Canada Inc. markets, develops research, and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia.